Back to YC Companies
Adventris Pharmaceuticals
Winter 2023
Active
Adventris makes cancer vaccines
7 people View on YC
Adventris Pharmaceuticals at a glance
- Y Combinator batch
- Winter 2023
- Status
- Active
- Industry
- Healthcare
- Team size
- 7 people
- Location
- Not recorded
- Website
- Not recorded
Every field above comes from the Y Combinator company record. Nothing is estimated.
Compare Adventris Pharmaceuticals with similar YC companies →
About Adventris Pharmaceuticals
Adventris makes cancer vaccines. Our platform solves the problem of targeting poorly immunogenic oncogenes. Our first "off-the-shelf" vaccine targets KRAS, the most common cancer oncogene. In the long run, we envision a world where every adult receives our pan-cancer vaccines annually – preventing the majority of cancer deaths. If you are interested in learning more about our approach to treat and prevent cancer, please reach out to us at contact@adventris.com
Tags:
Biotech
Healthcare
Therapeutics
Drug discovery
Oncology